A method named rastin@FA-Exo can enhance exosome transport and folate receptor uptake in triple-negative breast cancer (TNBC) cells, thereby enabling targeted drug delivery
Maybe you've read that NAD is the longevity supplement to pay attention to, and now you're wondering whether NAC deserves shelf space in your stack, or whether it's a distraction dressed up in similar three-letter clothing
Today peptides, tomorrow homeopathy (...though at least for the latter, a presumption of safety would have a more rational basis) Eric, what feels especially important here is that the difficult question is not only whether a biological signal exists, but whether the strength of evidence matches the level of confidence required for clinical use
Jonkers IJ, Smelt AH, Princen HM, Kuipers F, Romijn JA, Boverhof R,
All plant GGTs were classified into the same branch, which was further divided into two distinct subgroups
The adverse reactions that occurred in placebo-controlled clinical trials in at least 2% of patients treated with amlodipine and valsartan but at a higher incidence in amlodipine/valsartan patients (n=1437) than placebo (n=337) included peripheral edema (5.4% vs 3%), nasopharyngitis (4.3% vs 1.8%), upper respiratory tract infection (2.9% vs 2.1%) and dizziness (2.1% vs 0.9%)
